Baltimore, MD | October 5-6, 2015

The Intersection of Data Privacy, Innovative Partnerships, Genetics and Ongoing Laboratory Hurdles

The Personalized/Precision Medicine Blog

The official blog of the Annual Personalized and Precision Medicine Conference provides readers with information, insight and analysis regarding the field of personalized and precision medicine, genomics, genomic interpretation and the evolution of healthcare in the post-genomic era.

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Login
    Login Login form

Review and Interpretation of FDA’s Draft Guidance for Regulation of Lab-Developed Tests

Posted by on in Uncategorized
  • Font size: Larger Smaller
  • Hits: 374
  • 0 Comments
  • Subscribe to this entry
  • Print

Foley & Hoag’s Bruce Quinn, MD, Ph.D., a national expert on Medicare policy and health reform has offered his thoughts on the FDA’s recent notice of intent to issue draft guidance for regulation of lab-developed tests (LDTs) in a couple of forums recently. Here are the urls:

http://tinyurl.com/l2awysc

http://tinyurl.com/kqaejrm

 

Dr. Quinn will be discussing the radically changing market for lab test pricing (PAMA 2014 and beyond) at Arrowhead’s 6th Annual Personalized Medicine Conference on October 29-30, 2014 in San Francisco, CA.

An additional highlight of this year’s conference will be a three-way conversation on the different perspectives on pricing and reimbursement of lab tests between the government, diagnostic and other industries, moderated by Dr. Quinn, and featuring:

Louis Jacques, MD, Sr. VP & Chief Clinical Officer, ADVI (formerly the Director, Coverage & Analysis Group at CMS)

Paul Billings, MD, Ph.D., Chief Medical Officer, Omicia (formerly the Chief Medical Officer, Life Technologies, Inc.)

Chris Hall, Chief Commercial Officer, Veracyte

Visit personalizedmedicinepartnerships.com for more information.

Rate this blog entry:
0


John Waslif is the Managing Director of Arrowhead Publishers and Conferences and the Producer of their Annual Personalized Medicine Conference, which brings together multiple stakeholders, including payers, molecular diagnostics companies, genome analysis/interpretation companies, clinicians and many others in order to provide attendees with a holistic view of the personalized and precision medicine landscape.

Comments

  • No comments made yet. Be the first to submit a comment

Leave your comment

Guest Tuesday, 07 April 2015

About Us

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward. Learn more about us at www.arrowheadpublishers.com.

Contact Us

For general information about the conference, please contact us at:
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 +866.945.0263
 +866.945.0263
 5780 Lincoln Drive, Suite 205, Edina, Minnesota 55436 USA